The Child Health Advantage program has contracted with GlaxoSmithKline (GSK) for vaccines since 2001. GSK is a fortune 500 pharmaceutical company headquartered in the UK with operations based in the US. GSK conducts research for both medicines and vaccines. GSK is a pharmaceutical industry leader, with an estimated seven percent of the world's pharmaceutical market.

The GSK contract offers discounted pricing as well as quarterly rebates based on the number of doses purchased. In 2009 participating physician offices received over $10.2 million in rebates. Click here for information on the GSK vaccines available on contract.